Treatment of malignant germ cell tumors

Einhorn, 1982, The role of maintenance therapy in disseminated testicular cancer, New Engl J Med, 305, 727, 10.1056/NEJM198109243051303 Schultz, 1984, Testicular seminoma in Denmark 1976–1980, results of treatment, Ada Radiol Oncol, 23, 263 Von der Maase, 1984, Non-seminomatous testicular germ cell tumors in Denmark 1976–1984, remits of treatment, Acta Radiol Oncol, 23, 255, 10.3109/02841868409136021 Rørth, 1985, Treatment of non-seminomatous testicular germ cell tumors in Denmark since 1979, 539 Krag, 1990, Histopaihological features in stage I non-seminomatous testicular germ cell tumours correlated to relapse, Acta Palhologica Microbiologica Scandinavia Peckham, 1983, The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cisplatin (BEP), Br J Cancer, 47, 613, 10.1038/bjc.1983.99 Fraley, 1979, Germ-cell testicular cancer in adults, New Engl J Med, 301, 1370, 10.1056/NEJM197912203012504 Berthelsen, 1981, Distribution of carcinoma-in-situ in testes from infertile men, Int J Androl, 172, 10.1111/j.1365-2605.1981.tb00672.x Daugaard, 1986, High-dose cisplatin and VP-16 with bleomycin in the management of advanced metastalic germ cell tumors, Eur J Cancer Clin Oncol, 22, 477, 10.1016/0277-5379(86)90115-X Schultz, 1984, Testicular carcinoma in Denmark 1976–1980. Stage and selected clinical parameters at presentation, Acta Radiol Oncol, 249, 10.3109/02841868409136020 Oliver, 1987, Limitations to the use of surveillance as an option in the management of stage I seminoma, Int J Androl, 10, 263, 10.1111/j.1365-2605.1987.tb00192.x Hamilton, 1986, Radiotherapy for stage I seminoma testis; results of treatment and complications, Radiother Oncol, 6, 115, 10.1016/S0167-8140(86)80017-2 Ball, 1982, The management of metastatic seminoma, Cancer, 50, 2289, 10.1002/1097-0142(19821201)50:11<2289::AID-CNCR2820501112>3.0.CO;2-X Peckham, 1987, Surveillance following orchiectomy for stage I testicular cancer, Int J Androl, 10, 247, 10.1111/j.1365-2605.1987.tb00190.x Freedman, 1987, Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone, Lancet, II, 294, 10.1016/S0140-6736(87)90889-0 Rørth, 1987, Orchiectomy alone versus orchiectomy plus radiotherapy in stage I non seminomatous testicular cancer. a randomized study by the Danish Testicular Carcinoma Study Group, Int J Androl, 10, 255, 10.1111/j.1365-2605.1987.tb00191.x Rørth, 1989, Management of patients with non-seminomatous germ cell tumors stage I. A position paper Pizzocaro, 1987, Retroperitoneal lymphnode dissection in clinical stage IIA and IIB non seminomatous germ cell tumours of the testis, Int J Androl, 10, 269, 10.1111/j.1365-2605.1987.tb00193.x Fraley, 1985, Surgical treatment of patients with stage I and II non seminomatous testicular cancer, J Urol, 134, 70, 10.1016/S0022-5347(17)46985-0 Hartlapp, 1987, Adjuvant chemotherapy in non seminomatous testicular tumor stage II, Int J Androl, 10, 277, 10.1111/j.1365-2605.1987.tb00194.x Niederle, 1984, Nichtseminomatose hodentumoren, Terapiwoche, 34, 3311 Williams, 1987, Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer, New Engl J Med, 317, 1433, 10.1056/NEJM198712033172303 Peckham, 1985, Clinical stage II non-seminomatous germ cell testicular tumours. Results of management by primary chemotherapy, Br J Urol, 57, 763, 10.1111/j.1464-410X.1985.tb07050.x Vogelzang, 1987, Prognostic factors in metastatic testicular cancer, Int J Androl, 10, 225, 10.1111/j.1365-2605.1987.tb00188.x Bosl, 1983, Multivariale analysis of prognostic variables in patients with metastatic testicular cancer, Cancer Res, 43, 3403 Birch, 1986, Prognostic factors for favorable outcome in disseminated germ cell tumors, J Clin Oncol, 4, 400, 10.1200/JCO.1986.4.3.400 Ozols, 1988, A randomized trial of standard dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ cell tumours, J Gin Oncol, 6, 1031, 10.1200/JCO.1988.6.6.1031 Williams, 1986, Disseminated germ cell tumors: superlority of a VP–16 containing regimen in patients with high tumor volume, Proc Am Soc Clin Oncol, 6, 385 Rørth, 1990, Dose escalation of cisplatin in chemotherapy of poor risk germ cell tumours Horwich, 1989, Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours, Eur J Cancer Clin Oncol, 25, 177, 10.1016/0277-5379(89)90005-9 Kaye, 1989, BOP/VIP - a new intensive regime for poor prognosis germ cell tumours, Proceedings of ASCO, 8, 530 Einhom, 1989, Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group Protocol, J Clin Oncol, 7, 387, 10.1200/JCO.1989.7.3.387 Burt, 1981, Genn-cell tumours in patients with apparently normal testis, Cancer, 47, 1911, 10.1002/1097-0142(19810401)47:7<1911::AID-CNCR2820470732>3.0.CO;2-J Feun, 1980, Vinblastine, bleomycin, cisdiamminedichloroplatinum in disseminated extragonadal germ cell tumours: a Southwest, Oncology Group Study, 45, 2543 Funes, 1981, Mediastinal germ cell tumors treated with cisplatin, bleomycin and vinblastine (PVB), Proc Am Assoc Cancer Res, 22, 474 Hainsworth, 1982, Advanced extragonadal germ cell tumors, Ann Intern Med, 97, 7, 10.7326/0003-4819-97-1-7 Daugaard, 1983, Therapy of extragonadal germcell tumors, Eur J Cancer Clin Oncol, 19, 895, 10.1016/0277-5379(83)90054-8 Kuzur, 1982, Endodermal sinus tumor of the mediastinum, Cancer, 50, 766, 10.1002/1097-0142(19820815)50:4<766::AID-CNCR2820500424>3.0.CO;2-X Logothetis, 1985, Chemotherapy of extragonadal germ cell tumors, J Clin Oncol, 3, 316, 10.1200/JCO.1985.3.3.316 Daugaard, 1987, Electrophysiological study of the peripheral and central neurotoxic effect of cisplatin, Acta Neurol Scan, 76, 86, 10.1111/j.1600-0404.1987.tb03551.x Daugaard, 1988, Renal tubular functions in patients treated with high-dose cisplatin, Clin Pharmacol Ther, 44, 164, 10.1038/clpt.1988.132 Daugaard, 1988, Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose, Cancer Chemother Pharmacol, 21, 163, 10.1007/BF00257365 Hansen, 1989, Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer, J Clin Oncol, 7, 1457, 10.1200/JCO.1989.7.10.1457 Hansen, 1989, Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cisplalinum, vinblastine and bleomycin: a long-term follow–up, Eur J Cancer Clin Oncol, 25, 733, 10.1016/0277-5379(89)90211-3 Hansen, 1989, Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin for germ cell cancer: measurement of vasoconstrictor response to cold, J Clin Oncol 1989;, 7, 940 Hansen, 1988, Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer, J Clin Oncol, 6, 1728, 10.1200/JCO.1988.6.11.1728 Von der Maase, 1986, Radiation treatment of carcinoma in situ testis, Lancet, 1, 624, 10.1016/S0140-6736(86)92853-9 Daugaard, 1987, Carcinoma in situ in patients with assumed extragonadal germ cell tumors, Lancet, II, 528, 10.1016/S0140-6736(87)92922-9